June 2018 | Volume 1
Robotics in Orthopaedic Surgery:
Answering Three Critical Questions
When analyzing the robotic technologies market, it's important to realize that many factors need to be considered - such as data.
Elos Medtech Commits New Investments to Orthopaedic Market
The company manufactures at facilities in China, Europe and the U.S., and derives ~30% of its revenue from orthopaedics.
Autocam, Flex-Cell, Orchid and Trumpf Talk Laser Marking
UDI has required companies to take a closer look at laser marking. Along with direct part marking, suppliers share ways that OEMs can benefit through precision, versatility, speed, cost-effectiveness and repeatability.
FDA Approves Artificial Intelligence Software for Wrist Fractures
This innovative technology uses
an algorithm to analyze x-ray images. Its creator, Imagen, was co-founded in part by doctors from the Hospital for Special Surgery.
Begin your OMTEC experience!
The Final Program is here!
See you next week, June 12-14!
You'll be in good company! View the
NN, Inc.'s Life Sciences Division to Exhibit at OMTEC
MedTech Momentum Expands into Europe with France Location
Sono-Tek Reports Revenue Growth
Cadence Adds PEEK Machining and Molding Capabilities
GF Machining Solutions Names Ellison Technologies as Distributor
Gauthier Biomedical Receives Patent for G10 Handle Line
UPS, WebOps Collaborate to Optimize Field Inventory
Additive Manufacturing Announcements
HP, Siemens Expand Additive Manufacturing Partnership
FMI Instrumed Increases Additive Capabilities with New 3D Printers
Additive Orthopaedics Gains FDA Clearance of Patient Specific Bone Segments
Eurocoating's Acquisition Aims to Build Additive Manufacturing "One-Stop-Shop"
White paper: Additive Manufacturing - An Investigation on the Re-use of Titanium Powder
Prototyping Survey: 37 Orthopaedic Device Manufacturers Respond
OEMs share their perspectives on prototyping, 3D printing, in-house vs. outsourcing, significant challenges and more.
Record and Report Minor Non-Conformances
The only time something is not reportable under 21 CFR Part 806 is when the product absolutely cannot result in an adverse health consequence.
X-Bolt Orthopaedics Completes Hip Fracture Trial Enrollment
DePuy Synthes' ATTUNE Knee Linked to Improved Quality of Life, Shorter LOS
Globus Medical Announces Positive LLIF Study Results
Cerapedics' i-FACTOR Demonstrates 50% Fusion Rate
Wenzel Spine Announces Case Study of VariLift-LX System
Did you miss it?
Top Tier Orthopaedic Companies Post Growth, Fuel $49 Billion Market
Combined revenue for the top-tier companies--DePuy Synthes, Zimmer Biomet, Stryker, Smith & Nephew, Medtronic, Arthrex and NuVasive--accounts for 66% of the total orthopaedic industry.
From the archives:
Yes, Your Work Influences Implant Purchasing
Product adoption will take teams of teams--contract manufacturers, suppliers and service providers included--to meet today's purchasing demands.
Copyright © 2018. All Rights Reserved.